Viral Vectors & Plasmid DNA Manufacturing Market to Worth Over US$ 20.30 Billion by 2033 | Astute Analytica

The surge is fueled by a rapidly expanding gene and cell therapy pipeline, with over 4,000 therapies in development and more ...

Charles River Enters Manufacturing Collaboration with Gazi University

Charles River Laboratories International, Inc. (NYSE: CRL) and Gazi University Faculty of Medicine, today announced a gene therapy contract development and manufacturing organization (CDMO) ...
GEN

New Standards Aim to Support Gene Therapy Manufacturers

U.S. Pharmacopeia (USP), the independent organization that helps develop quality standards for pharmaceuticals, has launched new standards for viral vectors that they hope will help the rapidly ...
GEN - Genetic Engineering and Biotechnology News

Bionova Scientific and Syenex Enter Plasmid DNA Alliance

Under the agreement, Bionova will serve as the preferred manufacturing partner for Syenex’s best-in-class delivery platforms.
The New York Times

Mutated DNA Restored to Normal in Gene Therapy Advance

The small study in patients with a rare disorder that causes liver and lung damage showed the potential for precisely targeted infusions. By Gina Kolata Researchers have corrected a disease-causing ...
Seeking Alpha

ProBio Opens Flagship U.S. Plasmid & Viral Vector Manufacturing Facility in Hopewell, New Jersey to Advance Cell and Gene Therapy

HOPEWELL, N.J., June 27, 2025 /PRNewswire/ -- ProBio, a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced the opening of its ...
The Scientist

CRISPR Therapy Progress and Prospects

Clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins are core components of fast-evolving therapeutic gene editing tools. Scientists have used CRISPR ...